Portuguese Neurologist Consensus on Cladribine Treatment for Multiple Sclerosis

A 2026 study used a Delphi methodology with 33 Portuguese neurologists to formulate consensus recommendations for managing cladribine tablet treatment in patients with relapsing-remitting multiple sclerosis. The dataset contains the statements and voting results on treatment schemes, patient selection, monitoring, safety, and family planning. It synthesizes expert opinion with evidence from clinical trials and real-world studies to guide clinical decision-making.

Use Cases

• Developing clinical guidelines based on expert consensus statements.
• Informing treatment decisions for relapsing-remitting MS patients based on defined selection and monitoring criteria.
• Comparing expert opinion on therapy switching and additional treatment cycles with trial data.
• Studying the application of the Delphi method in formulating medical consensus.

Strengths

• Based on a structured Delphi process involving 33 expert neurologists.
• Provides explicit consensus criteria (≥80% agreement on a five-point scale).
• Covers multiple critical clinical domains: treatment schemes, patient selection, safety, and family planning.

Limitations

• The dataset's internal structure (e.g., specific statements, vote counts) is not described in the provided metadata.
• Expert consensus is geographically limited to Portugal, which may affect generalizability.
• The row count and column names are not specified, limiting assessment of data completeness.

Provenance

Source

João de Sá

Collection Method

Delphi methodology with a panel of 33 Portuguese neurologists.

Time Range

2026

Freshness

Last updated 2026-03-23.

Geography

Portugal